Autopsy report · NCT03886012

Efficacy of a Transcranial Vibrating System for Mitigation of Migraine Associated Vertigo

“COVID-19 general concerns.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Suspended: paused, and may or may not restart.
• 40 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Na

Sponsor

Otolith Labs

Sponsor type

Industry

Conditions

Dizziness; Nausea; Headache; Confusion

Interventions

Otoband; Otoband sham

Participants

40 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• MORphine Use in the Fascia Iliaca Compartment Block With UltraSound
  “COVID-19 crisis.” (83% match in meaning)
• Long-term Surgical Therapeutic Outcomes of Peri-Implantitis
  “COVID-19 pandemic” (81% match in meaning)
• Evaluation of Cardiac Function With Cardio-respiratory Synchronized MRI
  “COVID-19” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.